Trials / Unknown
UnknownNCT02698124
Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice
Prospective Observation of the indUction Regimen for Acute Non-Promyelocytic Myeloid Leukemia in Elderly; Decitabine for Chemotherapy Unfit Korean Acute Myeloid Leukemia (AML) Patients in Real Practice
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 136 (estimated)
- Sponsor
- Ulsan University Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
Prospective multicenter, open-lab el, observational, single arm study of decitabine. Subjects will be elderly patients with newly diagnosed, treatment-naïve AML who are unfit to receive and not candidate for intensive induction chemotherapy (iIC)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Decitabine |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2019-08-01
- Completion
- 2022-12-01
- First posted
- 2016-03-03
- Last updated
- 2016-03-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02698124. Inclusion in this directory is not an endorsement.